Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid

Antoine Drieu1,2, Siling Du3,4,5, Steffen E Storck3,4

  • 1Center for Brain Immunology and Glia (BIG), Washington University in St Louis, St Louis, MO, USA. drieu@wustl.edu.

Nature
|November 9, 2022
PubMed

Insights

Parenchymal border macrophages (PBMs) regulate cerebrospinal fluid (CSF) flow by controlling arterial motion. Disrupting PBMs impairs brain clearance, highlighting their role in aging and Alzheimer's disease.

Area of Science:

  • Neuroimmunology
  • Cerebrospinal Fluid Dynamics
  • Macrophage Biology

Background:

  • Macrophages are crucial for tissue homeostasis.
  • Perivascular and leptomeningeal macrophages, termed parenchymal border macrophages (PBMs), are strategically located near the central nervous system (CNS) but their functions are understudied.
  • PBMs interact closely with cerebrospinal fluid (CSF).

Purpose of the Study:

  • To investigate the role of PBMs in CNS physiology and cerebrospinal fluid (CSF) dynamics.
  • To identify specific PBM subpopulations involved in regulating CSF flow.
  • To explore the implications of PBM dysfunction in aging and Alzheimer's disease (AD).

Main Methods:

  • Identification of LYVE1+ PBM subpopulation associated with the brain arterial tree.
  • Pharmacological and genetic depletion of PBMs to assess CSF flow.
  • Macrophage colony-stimulating factor (MCSF) administration to restore PBM function.
  • Single-nucleus RNA sequencing in human patients with Alzheimer's disease (AD) and a mouse model of AD.

Main Results:

  • PBMs, particularly LYVE1+ macrophages, regulate arterial motion essential for CSF flow dynamics.
  • PBM depletion leads to extracellular matrix accumulation, impaired CNS perfusion, and reduced clearance.
  • Age-related PBM dysfunction and impaired CSF dynamics were reversible with MCSF treatment.
  • Alzheimer's disease (AD) patients and mouse models show altered PBM pathways including phagocytosis, endocytosis, and interferon-γ signaling.

Conclusions:

  • Parenchymal border macrophages (PBMs) are identified as novel regulators of CSF flow dynamics.
  • Targeting PBMs offers a potential therapeutic strategy for brain clearance deficits in aging and Alzheimer's disease (AD).
  • Understanding PBM function is critical for maintaining CNS homeostasis and treating neurodegenerative conditions.